Normal Liver MRI Report Template (Dynamic Contrast, LI-RADS)
Normal liver MRI report template with dynamic and hepatobiliary phase contrast in a LI-RADS context: no observations, normal fat and iron, biliary tree, vasculature, spleen and pancreas, with notes on LI-RADS NC, threshold growth and the technical adequacy statement.
Rather not fill in the blanks? Type a few findings and get this report written ↓
EXAMINATION: MRI abdomen (liver protocol) with and without intravenous contrast. CLINICAL HISTORY: [indication, e.g. “Hepatocellular carcinoma surveillance in cirrhosis”] COMPARISON: None available. TECHNIQUE: Multiplanar multisequence MR imaging of the liver including axial T2, T2 fat-suppressed, in- and opposed-phase T1, diffusion-weighted imaging with ADC map, and pre-contrast and dynamic post-contrast fat-suppressed T1 images in the late arterial, portal venous and [delayed / transitional] phases, [with a 20-minute hepatobiliary phase,] after the intravenous administration of [x] mL of [gadolinium-based contrast agent]. Technical quality: adequate. FINDINGS: Liver: Normal size and contour. No surface nodularity or lobar redistribution. Homogeneous parenchymal signal on all sequences. No signal loss on opposed-phase imaging to suggest steatosis. No signal loss on in-phase or T2* imaging to suggest iron deposition. Homogeneous enhancement through all phases. No arterial-phase hyperenhancing observation, washout or enhancing capsule. [Homogeneous hepatobiliary phase uptake with no hypointense observation.] No LI-RADS observation. Biliary tree: No intrahepatic or extrahepatic biliary dilatation. Common bile duct measures [x] mm. Normal gallbladder without calculus or wall thickening. Portal and hepatic vasculature: The portal, splenic and superior mesenteric veins are patent with normal antegrade enhancement. No portal vein thrombus or tumor in vein. The hepatic veins and hepatic artery are patent. Spleen: Normal size, measuring [x] cm. No splenic lesion. Portosystemic collaterals: None. No varices, recanalized paraumbilical vein or splenorenal shunt. Pancreas: Normal signal and contour. No mass or ductal dilatation. Adrenal glands: Unremarkable. Kidneys: No solid renal mass. [Simple cysts measuring up to x cm.] Peritoneum: No ascites. Lymph nodes: No enlarged upper abdominal or portacaval lymph nodes. Bones and soft tissues: Unremarkable. IMPRESSION: 1. No LI-RADS observation. No arterial-phase hyperenhancing lesion, washout or threshold growth. Negative for hepatocellular carcinoma by LI-RADS criteria at this examination. 2. No imaging evidence of cirrhosis or portal hypertension. No hepatic steatosis or iron deposition. 3. Normal biliary tree, pancreas and spleen.
A sample dictation is ready below. Press generate, or type your own findings and end with “otherwise normal” to have the rest written out. No signup.
100 free reports over 14 days. No card, nothing to install.
Start your free trial →Please leave out patient identifiers. Text is de-identified before the AI sees it and is not stored. Demo output is not for clinical use.
Dictation notes
- State the technical adequacy and the phases obtained — LI-RADS is applied only to a technically adequate multiphase study in a patient at risk (cirrhosis, chronic hepatitis B or a prior HCC), and the arterial phase timing (late arterial, with the portal vein enhanced but hepatic veins not) is what a reviewer checks first.
- A “no observation” report has to say it: the surveillance impression is “No LI-RADS observation” or LR-NC when the study is non-diagnostic, not “no focal lesion”, because the referring hepatologist is tracking the category over time.
- Every observation is categorized LR-1 through LR-5, LR-M or LR-TIV by the major features (size, arterial-phase hyperenhancement, nonperipheral washout, enhancing capsule, threshold growth); an LR-3 is a 3-6 month follow-up, LR-5 is a treatment decision without biopsy, and the number drives both.
- Hepatobiliary phase hypointensity is an ancillary feature favoring malignancy, not a major feature — it can upgrade by one category to LR-4 at most, never to LR-5, and washout is assessed on the portal venous phase only when a hepatobiliary agent is used.
- Report steatosis and iron quantitatively when the sequences allow it (proton density fat fraction, R2*) rather than “mild signal loss”; both modify the appearance of any observation and are tracked by the hepatology clinic.
Related references
LI-RADS v2018 category calculator · Bosniak 2019 renal cyst classification
MyRadAgent’s radiology AI turns a scratch dictation into this report — structured, guideline-checked, in your own section headers and phrasing. It learns your style from every correction. Free trial: 100 reports over 14 days, no card, no IT ticket.
Draft a report with it → or try it here first — no signup ↑